Pages

Thursday, February 27, 2014

14 comments received by FDA so far Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act; Request for Nominations

source found here

No comments:

Post a Comment